Concepedia
Statistics
Publications
17
Citations
694
H-Index
14
Active since
2009
Affiliations
Erasmus MC(Current)
Erasmus University Rotterdam
Leiden University Medical Center
Rotterdam Eye Hospital
Chulalongkorn University
Benjamin Schrijver is an author at Erasmus MC specializing in life sciences, immunology, and inflammation.
Publications per year
2009–2022
Morbidly Obese Human Subjects Have Increased Peripheral Blood CD4+ T Cells With Skewing Toward a Treg- and Th2-Dominated Phenotype
Kim van der Weerd, Willem A. Dik, Benjamin Schrijver et al. · Diabetes · 2012 · 176 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Imatinib Mesylate and AMN107 Inhibit PDGF-Signaling in Orbital Fibroblasts: A Potential Treatment for Graves’ Ophthalmopathy
L. van Steensel, Benjamin Schrijver, Gemma M. Dingjan et al. · Investigative Ophthalmology & Visual Science · 2009 · 74 citations
Medicine, Ophthalmology, Pharmacotherapy +13
The JAK1/JAK2‐ inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release
Maud A.W. Hermans, Benjamin Schrijver, Conny C.P.A. van Holten‐Neelen et al. · Clinical & Experimental Allergy · 2018 · 64 citations · Full text
Life Sciences, Pharmacology, Pharmacotherapy +17
Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
Kornvalee Meesilpavikkai, Willem A. Dik, Benjamin Schrijver et al. · Arthritis & Rheumatology · 2019 · 60 citations · Full text
Medicine, Immunology, Neurology +17
A germline STAT6 gain-of-function variant is associated with early-onset allergies
Narissara Suratannon, Chupong Ittiwut, Willem A. Dik et al. · Journal of Allergy and Clinical Immunology · 2022 · 59 citations · Full text
Life Sciences, Genetics, Molecular Genetics +11
1–5 of 17